Callitas Theraputics Inc., a wholly owned subsidiary of Callitas Health Inc.

lthompson

About Lindsey Thompson

This author has not yet filled in any details.
So far Lindsey Thompson has created 39 blog entries.

Callitas Health Signs Product Development and Manufacturing Agreement with Lifestyles

2019-02-12T22:47:55-05:00

CINCINNATI, OH, February 13, 2019 – Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) a diversified clinical-stage pharmaceutical development, OTC consumer healthcare and proprietary cannabis delivery development and marketing company, announced today that it has signed a product development and manufacturing agreement with Lifestyles. “At LifeStyles, our mission is [...]

Callitas Health Signs Product Development and Manufacturing Agreement with Lifestyles2019-02-12T22:47:55-05:00

Callitas Health Signs Letter of Intent with NuEthix, LLC to Supply Cannastrip Technology in Nutrition and Fitness Segment

2019-02-07T16:28:42-05:00

CINCINNATI, OH, February 7, 2019 – Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development, OTC consumer goods marketing and cannabis delivery development company, announced today that it has signed a letter of intent with NuEthix, LLCto manufacture and supply proprietary formulations of CannaStrip products [...]

Callitas Health Signs Letter of Intent with NuEthix, LLC to Supply Cannastrip Technology in Nutrition and Fitness Segment2019-02-07T16:28:42-05:00

Callitas Health, Inc. Releases End-of-Year Update Letter to Shareholders

2018-12-18T21:06:55-05:00

CINCINNATI, OH (December 19, 2018) Callitas Health Inc.(CSE: LILY, OTCBB: MPHMF, FWB: T3F3), today announced that President and Chief Executive Officer, James Thompson, has issued the following letter to shareholders. Dear Shareholders: We would like to thank you for your continuing commitment as we strive to build Callitas Health into a strong player in the [...]

Callitas Health, Inc. Releases End-of-Year Update Letter to Shareholders2018-12-18T21:06:55-05:00

Callitas Health, Inc., Signs a Definitive Patent Technology Assignment Agreement to Acquire Additional Novel Cannabis Dosing Technologies

2018-10-02T09:51:11-05:00

CINCINNATI, OH, October 2, 2018 – Callitas Health Inc.(CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development, OTC consumer goods marketing and cannabis delivery development company, today announced that it signed a definitive Patent Technology Assignment Agreement with Ronald J. Thompson, MD to expand its cannabis delivery technology [...]

Callitas Health, Inc., Signs a Definitive Patent Technology Assignment Agreement to Acquire Additional Novel Cannabis Dosing Technologies2018-10-02T09:51:11-05:00

Callitas Health, Inc. Announces Corporate Update

2018-09-17T19:50:17-05:00

CINCINNATI, OH, September 18, 2018 – Callitas Health Inc.(CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, today announced that it has been notified by the British Columbia Securities Commission of regulatory deficienciesfor the second quarterended June 30, 2018. A cease trade [...]

Callitas Health, Inc. Announces Corporate Update2018-09-17T19:50:17-05:00

Callitas Health Announces Passing of Former CEO and President Gary A. Thompson

2018-09-17T19:47:15-05:00

CINCINNATI, OH, Sept. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) announced today with great sadness, that, Gary A. Thompson, former President and Chief Executive Officer of Callitas Health, died on September 11, 2018, after a long battle with cancer. Gary [...]

Callitas Health Announces Passing of Former CEO and President Gary A. Thompson2018-09-17T19:47:15-05:00

Callitas Health, Inc. Signs Partnership Agreement with BFS Innovations and PURE LEAF GROUP

2018-08-16T19:50:45-05:00

CINCINNATI, OH, August 16, 2018 – Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) today announced that it has signed a consulting agreement with BFS Innovations and Pure Leaf Group to launch Callitas’ patent-pending cannabis delivery technology and proprietary business model globally. "BFS Innovations and Pure Leaf Group are excited to be [...]

Callitas Health, Inc. Signs Partnership Agreement with BFS Innovations and PURE LEAF GROUP2018-08-16T19:50:45-05:00

Callitas Health Signs Letter of Intent with Lifestyles to Supply Unique Finished Goods for Retail Sale

2018-08-14T23:06:21-05:00

CINCINNATI, OH, August 14, 2018 – Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today it has signed a letter of intent with Lifestyles to supply unique finished goods for retail sale. “At LifeStyles, our mission is [...]

Callitas Health Signs Letter of Intent with Lifestyles to Supply Unique Finished Goods for Retail Sale2018-08-14T23:06:21-05:00

Callitas Health, Inc. Receives Full US Patent Grant for Treatment for Male Infertility (and Sub-Fertility)

2018-07-25T19:18:05-05:00

CINCINNATI, OH, (July 25, 2018) – Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today that the United States Patent and Trademark Office (USPTO) has granted US Patent #10,004,697 for the Company’s patent application for In Vivo Sperm Selection for [...]

Callitas Health, Inc. Receives Full US Patent Grant for Treatment for Male Infertility (and Sub-Fertility)2018-07-25T19:18:05-05:00

Callitas Health Launches Affiliate Network to Expand Reach for ToConceive

2018-07-10T10:25:04-05:00

CINCINNATI, OH, July 10, 2018 – Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and OTC consumer goods marketing company, announced today it has launched its new affiliate network for ToConceive through W4 Performance Ad Market. “W4 is excited by the potential of ToConceive [...]

Callitas Health Launches Affiliate Network to Expand Reach for ToConceive2018-07-10T10:25:04-05:00